Dr. Howard Bernstein M.D., Ph.D. Net Worth

Dr. Howard Bernstein M.D., Ph.D. biography

Dr. Howard Bernstein M.D., Ph.D. is the Chief Scientific Officer at SQZ Biotechnologies Co.

What is the salary of Dr D?

As the Chief Scientific Officer of SQZ Biotechnologies Co, the total compensation of Dr D at SQZ Biotechnologies Co is $546,521. There are 2 executives at SQZ Biotechnologies Co getting paid more, with Dr. Armon R. Sharei Ph.D. having the highest compensation of $692,569.

How old is Dr D?

Dr D is 64, he's been the Chief Scientific Officer of SQZ Biotechnologies Co since . There are 1 older and 6 younger executives at SQZ Biotechnologies Co. The oldest executive at SQZ Biotechnologies Co is Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD, 72, who is the Co-Founder & Member of Scientific Advisory Board.

What's Dr D's mailing address?

Howard's mailing address filed with the SEC is 200 ARSENAL YARDS BLVD, SUITE 210, , WATERTOWN, MA, 02472.

Insiders trading at SQZ Biotechnologies Co

Over the last 4 years, insiders at SQZ Biotechnologies Co have traded over $3,939 worth of SQZ Biotechnologies Co stock and bought 2,233,026 units worth $35,530,795 . The most active insiders traders include Holdings (Private) Ltd Temasek, Public Equities, L.P.Minne ... a Amy W Schulman. On average, SQZ Biotechnologies Co executives and independent directors trade stock every 50 days with the average trade being worth of $78,593. The most recent stock trade was executed by Richard Capasso on 15 August 2022, trading 1,183 units of SQZ stock currently worth $3,939.

What does SQZ Biotechnologies Co do?

SQZ Biotechnologies Co executives and stock owners

SQZ Biotechnologies Co executives and other stock owners filed with the SEC include:

• Dr. Armon R. Sharei Ph.D.,
  Co-Founder, Pres, CEO, Interim Principal Financial Officer & Director
• Teri Loxam,
  Consultant & Advisor
• Dr. Howard Bernstein M.D., Ph.D.,
  Chief Scientific Officer
• Lawrence J. Knopf,
  Gen. Counsel & Sec.
• Micah Zajic,
  Chief Bus. Officer
• Ipsita Roymoulik Ph.D.,
  Sr. VP of CMC & QUALITY
• Dr. Marshelle Smith Warren M.D.,
  Chief Medical Officer
• David First,
  Chief People Officer
• Dr. Howard Bernstein,
  Chief Scientific Officer
• Richard V. Capasso CPA,
  Chief Accounting Officer
• Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD,
  Co-Founder & Member of Scientific Advisory Board
• Micah Zajic,
  Chief Financial Officer
• Howard Phd Md Bernstein,
  Interim Chief Executive Office
• Holdings (Private) Ltd Temasek,
  10% owner
• Oliver Rosen,
  Chief Medical Officer
• Paul Bolno,
  Director
• Sapna Srivastava,
  Director
• Teri Loxam,
  Chief Financial Officer
• Pushkal Garg,
  Director
• Klavs F. Jensen,
  Director
• International Group, Inc. A...,
  10% owner
• Marc Elia,
  Director
• David First,
  Chief People Officer
• Armon Sharei,
  President and CEO
• Amy W Schulman,
  Director
• Marc Schegerin,
  Director
• Lawrence J Knopf,
  General Counsel
• Eric Moessinger,
  Director
• Schulman, As Trustee The Ar...,
  10% owner
• Public Equities, L.P.Minne ...,
  
• Management Co. Vii, L.L.C.P...,
  
• Bernard Coulie,
  Director
• Patrick V.J.J. Vink,
  Director
• Richard Capasso,
  See Remarks
• Marshelle Smith Warren,
  Chief Medical Officer